Clinical Trial Update: Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating virologic responses to new nucleoside regimens after prolonged ZDV or ddI monotherapy in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED